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Final-Stage Site-Selective Acylation for the Total Syntheses of 
Multifidosides A-C by Organocatalysis 
Yoshihiro Ueda, Takumi Furuta, and Takeo Kawabata* 
Abstract: The first total syntheses of multifidosides A-C have been 
achieved. The synthetic strategy is characterized by catalytic site-
selective acylation of protecting-group-free precursors 5a-c (also 
natural glycosides) at the final stage. High functional-group-tolerance 
of the site-selective acylation promoted by organocatalyst 4 enabled 
conventionally difficult molecular transformation in a predictable and 
reliable manner. An advantage of this strategy is to avoid the risks of 
undesired side reactions during the removal of the protecting groups 
at the final stage of the total synthesis, which we actually 
encountered in our attempted total synthesis and also have been 
reported in the literature. 
Predictability is one of the most important factors for designing 
the strategy of target-oriented synthesis[1] because rational 
retrosynthesis relies on the chemical transformations with 
predictable selectivity. Retrosynthetic analyses have been 
proposed based on the expected chemo-, diastereo-, and/or 
enantioselectivity of the corresponding reactions. In addition to 
these selectivities, site-selectivity has been a current focus as a 
key factor to streamline the synthetic routes to complex 
molecules[2-4]. Recently, we reported total synthesis of natural 
glycosides of an ellgitannin family based on site-selective 
introduction of galloyl groups to unprotected glucose at an early 
stage of the total synthesis[5]. Here we report the first total 
syntheses of natural glycosides, multifidosides A, B, and C, via 
final-stage site-selective acylation (Figure 1). In the most cases 
of total syntheses, the final step is employed for deprotection of 
the protective groups. It has been believed that the key reaction 
should not be run at the final step because synthetic efforts may 
be hampered by the final step if the key reaction did not take 
place in the expected manner. On the other hand, the present 
site-selective acylation was found to be suitable to be performed 
at the final stage of the total synthesis, because the site-
selectivity was maintained throughout the acylation of various 
natural glycosides precursors without exception, and thus, this 
site-selective molecular transformation seems predictable and 
reliable[6]. Recently, late-stage site-selective functionalization of 
biologically active compounds has been receiving increasing 
attention because it enables diversification of biologically active 
compounds retaining their original activity[7]. Final-stage site-
selective functionalization is expected to be a more promising 
entry to conveniently providing natural products and their 
derivatives with the related biological activity.  
   Synthetic targets 1-3 (Figure 1) were isolated in 2008 by Zhao 
and co-workers from whole plants of Pteris multifida used for a 
traditional Chinese medicine[8]. Compounds 1 and 2 were 
reported to have significant cytotoxicity against HepG2 tumor 
cells. These glycosides possess a p-coumaroyl group at C(4)-
OH of the glucopyranose moiety. A retrosynthetic analysis of 1 
and 2 is shown in Figure 1. While properly protected precursor 6 
with the free C(4)-OH (route 2) is a rational precursor for the 
synthesis of 1 and 2 based on the conventional 
protection/deprotection strategy, we envisioned to introduce the 
p-coumaroyl group directly onto the C(4)-OH of the protecting-
group-free precursor 5 by site-selective acylation with 
organocatalyst 4 (route 1). In light of high functional-group-
tolerance observed in the previously reported site-selective 
acylation reactions,[5,6] we anticipated that the desired 4-O-
acylation would take place through the hypothetical transition 
state (Figure 1) in the presence of otherwise more reactive 
primary hydroxy group(s) and other hydrogen-bond acceptors. 
The expected advantages of the present strategy would involve 
(1) a proposal of an unconventional retrosynthetic route to 
natural glucosides with C(4)-O-acylated glucopyranose 
substructure, (2) shorter synthetic steps by streamlining the 
synthetic scheme, and (3) avoidance of the risks of the 
undesired side reactions during the removal of the protecting 
groups (PGs) at the later stage, which we actually encountered 
in our attempted total synthesis (see Scheme 3). The examples 
of undesired side reactions at the late-stage deprotection have 
also been reported toward to the synthesis of phenylethanoid 
glycosides, which include acyl migration, over reduction, and 
isomerization of the double bond[9]. Notably, the proposed 
synthetic scheme realizes an one-step conversion from a natural 
glycoside to other natural glycoside, since precursor 5 is also a 
naturally occurring glycoside, wallichoside[10].  
   A retrosynthetic analysis for natural glycosides 5a-c (5a:  
(2S,3S)-wallichoside, 5b: (2R,3S)-wallichoside, 5c: pteroside B),  
 
Figure 1. Structures of multifidosides A-C and synthetic strategy: route 1 (this 
work); organocatalytic final-stage site-selective acylation of the protecting-
group-free precursor, 5 and route 2; conventional strategy using a properly 
protected precursor, 6. 
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the precursors of target natural glycosides 1-3, is shown in 
Scheme 1. Glycosides 5a-c would be obtained by β–selective 
glycosylation of aglycons 8a, 8b, and 10 with commercially 
available glycosyl donor 11 followed by debenzylation. Aglycons 
8a, 8b, and 10 are also natural products known as (2S,3S)-
pterosin C, (2R,3S)-pterosin C, and (2R)-pterosin B[10], 
respectively. The β-hydroxyketone moiety of 8a and 8b would be 
constructed by an organocatalytic intramolecular asymmetric 
aldol reaction of aromatic ketoaldehyde 12. Although the relative 
stereochemistry of the aldol reaction could not be predicted at 
this stage, both the syn- and anti- isomers were required 
because they both are constituents of the natural products, and 
the interconversion between them seemed possible by 
epimerization at C(2). Aglycon 10 would be readily obtained by 
reductive removal of the hydroxy group of 8b[11]. 
   Total synthesis of 2 was investigated at first (Scheme 2). The 
aldol precursor 12 was prepared from commercially available 
tetra-substituted benzene 13. Consecutive lithium-halogen 
exchange of 13 followed by hydroxyethylation and formylation of 
the respective aryl lithium species afforded a tri-substituted 
benzaldehyde derivative, which was then converted to 14 by 
reduction of the formyl group and methoxycarbonylation of the 
resulting alcohol. After iodination of 14 with I2 and PIFA[12], 
intramolecular O to C acyl migration of the aryl magnesium 
species generated by iodine-magnesium exchange of the 
resulting aryl iodine followed by methanolysis gave lactone 15. 
Protection of the primary hydroxy group of 15 with a TBDPS 
group, addition of a Grignard reagent to the lactone, followed by 
Ley oxidation[13] of the resulting lactol gave aldol precursor 12. 
    Then, the asymmetric intramolecular aldol reaction of keto-
aldehyde 12 was investigated. Since List, Lerner, and Barbas 
reported the direct asymmetric aldol reaction between aliphatic 
ketones and aldehydes catalyzed by L-proline[14], a tremendous 
number of organocatalytic asymmetric aldol reactions and 
related reactions have been reported[15]. However, there are only 
limited examples of direct aldol reactions using arylalkylketones 
as aldol donors because of the poor reactivity[16]. After thorough 
screening of catalysts and the conditions (Table S1), we found 
that proline derivative 16[17] has reactivity sufficient to give 9b 
with the desired absolute and relative configuration (88% yield, 
syn:anti=98:2, 85% ee for the syn isomer). To the best of our 
knowledge, this is the first successful example of the asymmetric 
intramolecular aldol reaction of aromatic ketoaldehydes 
catalyzed by proline or its analogues. β-Selective glycosylation 
of 9b (85% ee) took place by treatment with commercially 
available glycosyl donor 11a and BF3·Et2O in EtCN[18] to give a 
diastereomeric mixture of the β-glycosides resulting from a 
92.5 : 7.5 enantiomeric mixture of 9b. Diastereomerically pure 
17b, obtained by the removal of the minor diastereomer, was 
subjected to the removal of TBDPS and Bn groups to afford 5b, 
the proposed precursor for 2. 
    Organocatalytic site-selective coumaroylation of 5b was next 
investigated toward the total synthesis of 2. The use of less-
coordinating solvents such as CHCl3 or toluene was claimed to 
be critical for achieving high site-selectivity of the acylation of 
glycopyranoses catalyzed by 4[6], which was assumed to be due 
to the effective hydrogen-bonding interaction in these solvents 
as shown in Figure 1. However, 5b, the substrate for the p-  
 
Scheme 1. Retrosynthetic analysis for 5a-c. 
 
Scheme 2. Total synthesis of multifidoside B (2). Reagents and conditions: a) 
n-BuLi, Et2O, –78 °C; ethylene oxide, –78 °C to r.t., 87%; b) n-BuLi, THF, –78 
to –30 °C; DMF, –78 °C to r.t., 92%; c) NaBH4, MeOH, 0 °C; d) methyl 
chloroformate, pyridine, DMAP (5 mol%), DCM, r.t., 87% (2 steps); e) I2, PIFA. 
CH3CN, r.t., 93%; f) i-PrMgCl, THF, 0 °C; MeOH, reflux, 85%; g) TBDPSCl, 
imidazole, r.t., 92%; h) EtMgBr, THF, 0 °C; i) TPAP (5 mol%), NMO, NMM, MS 
4Å, DCM, r.t., 83% (2 steps); j) 11a (X =β-F), BF3·Et2O, MS 4Å, EtCN, -78 to 
0 °C, 84%; k) HF·pyridine, THF, r.t., 97% l) BBr3, DCM, –78 °C, 76%. 
coumaroylation possessing five free hydroxy groups, was totally 
insoluble in CHCl3 or toluene. Instead of these 
solvents,CHCl3/DMSO (9/1) was found to be effective for the 





site-selective acylation at the C(4)-OH of the glucopyranose 
derivative irrespective of the strongly hydrogen-bond accepting 
nature of DMSO[19]. TES-protected anhydride 18 was employed 
as an acylating reagent because the use of acid anhydrides 
rather than acid chlorides was critical for the site-selectivity[6a] 
and the TES group was expected to be readily removed at the 
work-up process. As expected, site-selective acylation of 5b 
catalyzed by 4 took place at the desired site to give natural 
glycoside 2 directly in 54% isolated yield (91% site-selectivity 
among the monoacylates obtained in 59% yield). This result 
showed that the site-selective acylation is highly functional-
group tolerant in the presence of many potentially nucleophilic 
hydroxy groups, hydrogen-bond donors (-OH) and acceptors 
(ketone, ethereal oxygen). The surprising functional-group 
tolerance of the site-selective acylation makes the present 
strategy reliable and predictable[20]. 
    This strategy provides additional advantages in the total 
synthesis by avoiding the risks of undesired side reactions 
(Scheme 3). For example, attempted total synthesis of 2 using 
partially protected precursor 18b resulted in the double-bond 
isomerization to give an E/Z (2/1) mixture of 2 by the final-step 
deprotection of the OTBDPS group in 20 with TBAF/AcOH or 
HF/pyridine. Whereas the double bond in the hydroxy cinnamoyl 
group of the natural products has been reported to easily 
undergo E,Z-isomerization[9c,21], only a small extent of E,Z-
isomerization of 2 was observed (E/Z = 20~10/1) in our strategy 
shown in Scheme 2 (Natural products 1, 2, and 3 also contain a 
small amount of the Z-isomer, see Supporting information Figure 
S1-S3). Another attempt to obtain 2 by treatment of 20 with 
TBAF hampered the efforts to the total synthesis, and gave 
decomposed product 21 as the major product by β-elimination of 
the glucose moiety[22]. In the literature for the total synthesis of 4-
O-acylated glycoside natural products, undesired side reactions 
such as acyl migration from the desired 4-O-acylate to the 
undesired 6-O-acylate and over-reduction and isomerization of 
the cinnamoyl moiety by the final-step deprotection have been 
reported[9]. These problems could be avoided when the present 
strategy with protecting-group-free precursors is employed. 
   Total syntheses of 1 and 3 were performed by the similar 
procedure to that for the synthesis of 2 (Scheme 4). 
Epimerization at the carbonyl α-carbon of 17b took place by the 
careful basic treatment at 0 °C to give a 86:14 mixture of 17a 
and 17b without β-elimination of the glucose moiety (Scheme 
4A). Separation of the resulting diastereomers gave 17a as a 
pure diastereomer in 70% yield. (2S,3S)-Wallichoside (5a) was 
obtained by removal of the protective groups of 17a. 
Organocatalytic site-selective coumaroylation of 5a with five free 
hydroxy groups took place also in a predictable manner to give a 
natural product, multifidoside A (1), in 54% isolated yield 
(Scheme 4A, 84% site-selectivity among the monoacylates 
obtained in 64% yield). Aglycon 10, the proposed precursor of 3, 
was prepared by Barton-McComby deoxygenation[23] of 9b 
followed by desilylation (Scheme 4B). Glycosylation of 10 by 
Schmidt’s procedure[18b,24] followed by hydrogenation of the 
resulting glycoside gave pteroside B[10] (5c). Total synthesis of 
multifidoside C (3) was achieved by catalytic site-selective 
coumaroylation of 5c in 70% isolated yield (90% site-selectivity 
among the monoacylates obtained in 78% yield). Thus, total 
syntheses of natural glycosides, multifidosides A, B, and C, were 
accomplished via final-stage organocatalytic site-selective 
coumaroylation of the precursors with multiple free hydroxyl 
groups. 
   The desired site-selectivity was maintained throughout the 
acylation of the glycosides with various aglycon moieties. 
Another advantage of this strategy is the direct and facile 
diversification of natural glycosides (Scheme 5). Isobutyryl, 
benzoyl, and N-Cbz-α-aminoacyl groups were introduced to the 
expected hydroxy group of a natural glycoside, (2R,3S)-
wallichoside (5b), in up to 97% site-selectivity by the protocol 
described above. The biological activity of carbohydrates 
possessing acyl group(s) often depends on the position and 
structure of the acyl group(s)[25,26]. Therefore, the site-selective 
introduction of various acyl groups at the final stage of the 
synthesis may be applicable to searching for the biologically 
active analogues. 
    In conclusion, the first total syntheses of multifidosides A (1), 
B (2) and C (3) have been accomplished in 15 steps (8.2% 
overall yield), 14 steps (12% overall yield), and 16 steps (11% 
overall yield), respectively, from commercially available reagents.  
 
Scheme 3. Our problems encountered at the later-stage deprotection toward 
total synthesis of 2.  
 





Scheme 4. Total syntheses of (A) 1 and (B) 3. Reagents and Conditions: a) 
DBU, toluene, 0 °C, 70%; b) HF·pyridine, THF, r.t., 94%; c) BBr3, DCM, –
78 °C, 74%; d) 22, 4 (20 mol%), collidine, CHCl3/DMSO (9/1), -40 °C, 168 h; 
HF·pyridine, -40 °C, 2 h; e) 4-FC6H4OCSCl, DMAP, DCM, r.t., 88%; f) n-
Bu3SnH, AIBN (20 mol%), benzene, 100 °C, 75%; g) HF·pyridine, THF, r.t., 
91%; h) 11b, TMSOTf (10 mol%), CH3CN, –40 °C, 83%, (s) Pd(OH)2/C, H2, 
AcOEt/MeOH (1/1), r.t., 82%. 
 
Scheme 5. Final-stage site-selective diversification of a natural product, 
(2R,3S)-wallichoside (5b). 
The key step is the final-stage site-selective acylation of the 
protecting-group-free precursors by organocatalysis. Because of 
the predictability and reliability of the catalytic site-selective 
introduction of the various functionalized acyl groups, this 
synthetic strategy would provide a new retrosynthetic route to 4-
O-acylglycosides such as phenylethanoid glycosides[27] and 
ellagitannins[28] of biological interest. 
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proposed. Organocatalytic site-selective coumaroylation of the protective-group-
free precursors possessing multiple hydroxy groups was performed successfully at 
the final-stage of the total syntheses of multifidosides A, B, and C. The site-
selectivity was found to be predictable and reliable throughout the acylation of the 
various protective-group-free precursors.  
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